Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.66 |
| ▸ | MMP8 | P22894 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | KDR | P35968 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30772148 | 0.91 | MMP2 (0.82) | MMP2MMP8NPC1ALKPOLB | |
| SCHEMBL24993420 | 0.91 | MMP2 (0.82) | MMP2MMP8NPC1ALKPOLB | |
| SCHEMBL24993421 | 0.90 | MMP2 (0.80) | MMP2MMP8NPC1POLBMAPT | |
| SCHEMBL27840487 | 0.83 | MAPK1 (0.73) | MMP2MMP8NPC1ALKPOLB | |
| SCHEMBL30772150 | 0.82 | MMP2 (0.86) | MMP2MMP8NPC1MAPTLMNA | |
| SCHEMBL15401573 | 0.80 | MMP2 (0.76) | MMP2MMP8NPC1POLBMAPT | |
| SCHEMBL15401374 | 0.80 | MMP2 (1.00) | MMP2MMP8NPC1MAPTLMNA | |
| SCHEMBL30173490 | 0.79 | MMP2 (0.78) | MMP2MMP8NPC1ALKMAPT | |
| SCHEMBL27235580 | 0.79 | MMP2 (0.78) | MMP2MMP8NPC1ALKMAPT | |
| Hydrochloric Acid SCHEMBL31496761 | 0.79 | MMP2 (0.98) | MMP2MMP8NPC1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240180898-A1 | USE OF AMINOTHIAZOLE DERIVATIVE IN TREATMENT OF IMMUNE INFLAMMATION | INNAMUNE PHARMACEUTICAL CO. LTD. (CN) | 2024-06-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240180898-A1 | USE OF AMINOTHIAZOLE DERIVATIVE IN TREATMENT OF IMMUNE INFLAMMATION | AADAT, IDO1, IDO2 | MMP2 2870/4885MMP8 1107/4885NPC1 1302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.